Hunutlu, F. Ç. Et Al. 2025. Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy. Diagnostics , vol.15, no.2 .

Hunutlu, F. Ç., Öztop, H., Gürsoy, V., Ersal, T., Elgün, E., Yavuz, Ş., ... İldemir Ekizoğlu, S.(2025). Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy. Diagnostics , vol.15, no.2.

Hunutlu, FAZIL Et Al. "Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy," Diagnostics , vol.15, no.2, 2025

Hunutlu, FAZIL Ç. Et Al. "Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy." Diagnostics , vol.15, no.2, 2025

Hunutlu, F. Ç. Et Al. (2025) . "Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy." Diagnostics , vol.15, no.2.

@article{article, author={FAZIL ÇAĞRI HUNUTLU Et Al. }, title={Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy}, journal={Diagnostics}, year=2025}